NL
NL · NL · NL-111ba67bcb64
Gliclazide Aurobindo Retard 60 mg, tabletten met gereguleerde afgifte
ATC A10BB09
Last synced from CBG-MEB (Netherlands) on
Identification
ManufacturerAurobindo Pharma B.V.
CountryNL (NL)
ATC codeA10BB09
Dispensing—
ReimbursedNo
SourceCBG-MEB (Netherlands)
Last synced6/9/2026
Packs · 1
- cbg_meb_id131068
Annotations
No annotations yet.
Raw payload (JSON)
{
"form": "Tablet met gereguleerde afgifte",
"route": "Oraal gebruik",
"soort": "RVG",
"source": "cbg_meb",
"smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h131068_smpc.pdf",
"strength": null,
"atc_label": "Gliclazide",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg131068",
"excipients": [
"CALCIUMCARBONAAT (E 170)",
"HYPROMELLOSE (Release controlling polymer)(E 464)",
"HYPROMELLOSE 2208 (Release controlling polymer), K4M (E 464)",
"LACTOSE 1-WATER",
"MAGNESIUMSTEARAAT (E 470b)",
"SILICIUMDIOXIDE (E 551)"
],
"substances": [
"GLICLAZIDE"
],
"leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h131068.pdf",
"authorised_at": "2023/01/24",
"procedure_number": "PT/H/2550/002",
"dispensing_status": "Uitsluitend recept",
"registration_number": "131068",
"additional_monitoring": "N"
}Related drugs
Other records sharing ATC code A10BB09.
- CAAG-GLICLAZIDE MRANGITA PHARMA INC.
- CAAG-GLICLAZIDE MRANGITA PHARMA INC.
- CAAPO-GLICLAZIDEAPOTEX INC
- CAAPO-GLICLAZIDE MRAPOTEX INC
- CAAPO-GLICLAZIDE MRAPOTEX INC
- GBBilxona 30mg modified-release tabletsAccord-UK Ltd
- GBBilxona 60mg modified-release tabletsActavis UK Ltd
- GBBilxona 60mg modified-release tabletsAccord-UK Ltd
Access this data programmatically
Query Gliclazide Aurobindo Retard 60 mg, tabletten met gereguleerde afgifte and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.